Adding Talazoparib to Enzalutamide Prolongs Imaging-Based PFS in Metastatic Androgen Pathway Modulation-Sensitive Prostate Cancer with Alterations in HRR Genes By Ogkologos - June 15, 2026 30 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TALAPRO-3 study Source RELATED ARTICLESMORE FROM AUTHOR Mezigdomide-Carfilzomib-Dexamethasone Prolongs PFS Compared with Carfilzomib-Dexamethasone at First Relapse in Patients with Relapsed Or Refractory Multiple Myeloma FDA Approves Durvalumab in Combination with BCG for High-Risk Non-Muscle Invasive Bladder Cancer Systemic Aging Associated with a Higher Risk of Early-Onset Solid Cancers MOST POPULAR Low-Dose Aspirin Could be an Alternative to Colectomy for Preventing Colorectal... April 8, 2021 Breastfeeding Patterns and Relation to Breast Cancer Outcomes After Early, Hormone... July 23, 2025 ΠΩΣ ΠΡΟΚΑΛΕΙΤΑΙ January 18, 2019 Lymph Node Biopsies Are Unnecessary For Early-Stage Breast Cancer Patients, Study... January 7, 2020 Load more HOT NEWS Front-line CS1001 Plus Platinum-Based Chemotherapy Delivers Substantial Benefit in Advanced Non-Small... Could proton beam therapy improve throat cancer treatment? Pump Up the Volume: “Priming Agents” May Improve Cancer Liquid Biopsies Why it’s difficult to estimate the number of extra cancer deaths...
